These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8573955)

  • 1. Vigabatrin-associated reversible acute psychosis in a child.
    Cánovas Martínez A; Ordovás Baines JP; Beltrán Marqués M; Escrivá Aparisi A; Delgado Cordón F
    Ann Pharmacother; 1995 Nov; 29(11):1115-7. PubMed ID: 8573955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute psychosis and vigabatrin in childhood].
    Chiaretti A; Castorina M; Tortorolo L; Piastra M; Polidori G
    Pediatr Med Chir; 1994; 16(5):489-90. PubMed ID: 7885961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vigabatrin and psychosis.
    Sander JW; Hart YM; Trimble MR; Shorvon SD
    J Neurol Neurosurg Psychiatry; 1991 May; 54(5):435-9. PubMed ID: 1865207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The irreversible gamma-aminobutyrate transaminase inhibitor vigabatrin in the treatment of the alcohol withdrawal syndrome.
    Stuppaeck CH; Deisenhammer EA; Kurz M; Whitworth AB; Hinterhuber H
    Alcohol Alcohol; 1996 Jan; 31(1):109-11. PubMed ID: 8672169
    [No Abstract]   [Full Text] [Related]  

  • 5. Status epilepticus during vigabatrin treatment: a report of three cases.
    de Krom MC; Verduin N; Visser E; Kleijer M; Scholtes F; De Groen JH
    Seizure; 1995 Jun; 4(2):159-62. PubMed ID: 7670770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A risk-benefit assessment of vigabatrin in the treatment of neurological disorders.
    Srinivasan J; Richens A
    Drug Saf; 1994 May; 10(5):395-405. PubMed ID: 8037889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New drugs in the treatment of childhood epilepsy: vigabatrin (study of 61 subjects)].
    Raucci U; Spalice A; Basile LA; Guardalà C; Nasta L; Terenzi S; Iannetti P
    Pediatr Med Chir; 1994; 16(6):575-8. PubMed ID: 7708543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new anti-epileptic drugs.
    Murphy R
    Ir Med J; 1995; 88(6):198-9. PubMed ID: 8575915
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioural abnormalities and retention rates of anti-epilepsy drugs during long-term treatment of epilepsy: a clinical perspective.
    Schmidt D
    Acta Neurol Scand Suppl; 1995; 162():7-10. PubMed ID: 7495192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizures in a boy with succinic semialdehyde dehydrogenase deficiency treated with vigabatrin (gamma-vinyl-GABA).
    Matern D; Lehnert W; Gibson KM; Korinthenberg R
    J Inherit Metab Dis; 1996; 19(3):313-8. PubMed ID: 8803774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vigabatrin: results with a new antiepileptic agents in 57 patients in a general neurological practice].
    van der Zwan A; van der Zwan A
    Ned Tijdschr Geneeskd; 1994 Sep; 138(37):1859-63. PubMed ID: 7935922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vigabatrin--a new antiepileptic agent].
    Nakken KO; Henriksen O; Johannessen SI
    Tidsskr Nor Laegeforen; 1994 Oct; 114(24):2843-4. PubMed ID: 7998031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose vigabatrin (gamma-vinyl GABA)-induced damage in the immature rat brain.
    Sidhu RS; Del Bigio MR; Tuor UI; Seshia SS
    Exp Neurol; 1997 Apr; 144(2):400-5. PubMed ID: 9168839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute psychotic disorder associated with vigabatrin].
    Xavier M; Bento MS; Pereira DP; De Almeida JM
    Acta Med Port; 2000; 13(3):111-4. PubMed ID: 11026149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe persistent visual field constriction associated with vigabatrin.
    Eke T; Talbot JF; Lawden MC
    BMJ; 1997 Jan; 314(7075):180-1. PubMed ID: 9022432
    [No Abstract]   [Full Text] [Related]  

  • 16. Symptomatic and asymptomatic visual loss in patients taking vigabatrin.
    Daneshvar H; Racette L; Coupland SG; Kertes PJ; Guberman A; Zackon D
    Ophthalmology; 1999 Sep; 106(9):1792-8. PubMed ID: 10485552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotic and severe behavioural reactions with vigabatrin: a review.
    Ferrie CD; Robinson RO; Panayiotopoulos CP
    Acta Neurol Scand; 1996 Jan; 93(1):1-8. PubMed ID: 8825264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vigabatrin: balancing effectiveness vs. (irreversible) visual field loss as a side effect].
    Hardus P; Engelsman M; van Veelen CW; Stilma JS
    Ned Tijdschr Geneeskd; 2000 Oct; 144(43):2066-9. PubMed ID: 11072511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstructive sleep apnoea following rapid weight gain secondary to treatment with vigabatrin (Sabril).
    Lambert MV; Bird JM
    Seizure; 1997 Jun; 6(3):233-5. PubMed ID: 9203253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vigabatrin in unsatisfactory controlled epilepsies. Swiss Vigabatrin Study Group.
    Russ W
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(2):55-9. PubMed ID: 7569836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.